Navigation Links
Blood Clots in Legs, Lungs Predispose Patients to Repeat Episodes
Date:2/25/2008

They're at risk for new blockages within 3 years, study finds

MONDAY, Feb. 25 (HealthDay News) -- People who develop a blood clot in their legs (deep vein thrombosis) or in their lungs (pulmonary embolism) are at risk of developing another blood clot within three years, a new study suggests.

Deep vein thrombosis and pulmonary embolism are known collectively as venous thromboembolism.

Researchers looked at 1,691 people, average age 65, in Worcester, Mass., diagnosed with pulmonary embolism (549) and isolated deep vein thrombosis (1,142) in 1999, 2001 or 2003. During the three-year study, 31 (5.7 percent) of the pulmonary embolism patients had a recurrent clot in the lung, 75 (13.7 percent) had a recurrence of either type of venous thromboemolism, and 82 (14.9 percent) had a major bleeding episode (one that required blood transfusion).

Among the 1,142 patients with isolated deep vein thrombosis, 64 (5.6 percent) developed a pulmonary embolism, 217 (19 percent) had recurrent venous thromboembolism, and 146 (12.8 percent) had a major bleeding episode.

Patients with pulmonary embolism were more likely than those with deep vein thrombosis to die after one month (13 percent vs. 5.4 percent), one year (26 percent vs. 20.3 percent), and three years (35.3 percent vs. 29.6 percent).

"Patients whose course was complicated by major bleeding were more likely to experience recurrent venous thromboemolism or to die at three years than those without these complications," wrote Dr. Frederick A. Spencer, of McMaster University Medical Center in Hamilton, Ontario, Canada.

"Patients who presented with pulmonary embolism had similar rates of subsequent pulmonary embolism or recurrent venous thrombosis compared with patients with isolated deep vein thrombosis," the study authors noted.

"However, rates of recurrent venous thromboembolism and major bleeding after deep vein thrombosis and pulmonary embolism remain unacceptably high in the community setting. Efforts are needed to identify patients most at risk for venous thrombosis-associated complications and to develop better anti-coagulation strategies conducive to long-term use in the community setting," they concluded.

The study was published in the Feb. 25 issue of the Archives of Internal Medicine.

More information

The U.S. National Heart, Lung, and Blood Institute has more about deep vein thrombosis.



-- Robert Preidt



SOURCE: JAMA/Archives journals, news release, Feb. 25, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Mechanism of blood clot elasticity revealed in high definition
2. Indiana Blood Center Signs BIO-key(R) Contract
3. Current Blood Sugar Control Test Results Inaccurate
4. Another way to grow blood vessels
5. Study identifies another strategy for normalizing tumor blood supply
6. Standard test for blood sugar control not accurate in diabetic dialysis patients
7. Mix-Up Behind FDAs Failure to Inspect China Blood-Thinner Plant
8. UNT Health Science Center and The Center for Cancer and Blood Disorders Collaborate on New Institute for Cancer and Blood Disorders
9. Blood pressure drug may have added benefit
10. Two Laptop Computers Missing From Lifebloods Main Office
11. Airplane Noise Boosts Blood Pressure Even During Sleep
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Blood Clots in Legs, Lungs Predispose Patients to Repeat Episodes
(Date:5/28/2017)... ... ... Viewers likely know Rob Lowe from such 80s hits as St. Elmo’s Fire and ... The West Wing and Parks and Recreation. But recently, Lowe’s leant his talents to ... on important modern-day issues that face today’s society. One of the most recent episodes ...
(Date:5/27/2017)... ... May 27, 2017 , ... Most us are familiar with the sound of ... from the Osteoarthritis Initiative shows that certain people who experience consistent joint popping, ... may give doctors the opportunity to treat patients before the problem becomes pronounced, potentially ...
(Date:5/26/2017)... ... 2017 , ... Amir Qureshi, MD is the first physician in Arkansas to ... system. The Nuvectra™ Algovita SCS System has been FDA approved as a treatment option ... Arkansas to introduce the most powerful SCS system and the only stretchable lead on ...
(Date:5/26/2017)... , ... May 26, 2017 , ... On May 24, ... which narrowly passed the U.S. House on May 4, would result in 23 million ... under continued implementation of the 2010 Patient Protection and Affordable Care Act (ACA). ...
(Date:5/26/2017)... ... May 26, 2017 , ... Dr. Alex Rabinovich, a highly-skilled oral ... new, informational blog post on insurance options. If a Bay Area patient has to ... save time and money. Visiting an in-network provider for a second opinion can ensure ...
Breaking Medicine News(10 mins):
(Date:5/11/2017)... May 11, 2017  Thornhill Research Inc. ( ... awarded an $8,049,024 USD five-year, firm-fixed-priced, indefinite-quantity/indefinite-delivery contract ... Canadian Commercial Corporation (CCC) ( Ottawa, Ontario, ... to administer general anesthesia to patients requiring emergency ... "The US Marine Corps have been a longtime ...
(Date:5/10/2017)... , May 10, 2017 CSSi, the ... for the clinical research industry, is proud to announce ... . The new website features both enriched content and ... experience and enhances the company,s already well-established position as ... "After many months of hard work, ...
(Date:5/8/2017)... NEW YORK , May 8, 2017 ... in the transition from fee for service reimbursement. Black ... April 2017. 1.       The Market for ... 77% of physician practices with 3 or ... Compliance Technology Solutions by Q4. "Given the magnitude of ...
Breaking Medicine Technology: